MS402
MS402 is a BD1-selective BET BrD inhibitor with Kis of 77 nM, 718 nM, 110 nM, 200 nM, 83 nM, and 240 nM for BRD4 (BD1), BRD4 (BD2), BRD3 (BD1), BRD3 (BD2), BRD2 (BD1) and BRD2 (BD2), respectively. MS402 blocks Th17 cell differentiation and ameliorates colitis in mice[1].
Product Specifications
CAS Number
1672684-68-2
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Epigenetic Reader Domain
Type
Reference compound
Related Pathways
Epigenetics
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/ms402.html
Purity
98.36
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(NC1=CC=C(OC)C=C1)C2=CC=C(NC3=C(C)C(CC3)=O)C(Cl)=C2
Molecular Formula
C20H19ClN2O3
Molecular Weight
370.83
Precautions
H302, H315, H319, H335
References & Citations
[1]Cheung K, et al. BET N-terminal bromodomain inhibition selectively blocks Th17 cell differentiation and ameliorates colitis in mice. Proc Natl Acad Sci U S A. 2017 Mar 14;114 (11) :2952-2957.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
BRD2; BRD3; BRD4
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15371594 1 Vial
Lentiviral human MXD3 sgRNA gene knockout kit - Lentiviral human MXD3 sgRNA gene knockout kit (plasmid)
Sign In for Pricing
View Details 